Objective. To describe trends in registered HIV indicators and regional dif erencesinTajikistan using data reported in a dissertation. Materials and methods. A secondary descriptive retrospective analysis was performedusing aggregate annual HIV registration data for 2015–2024, selected mortalityandregional indicators, and reported transmission categories for 2005 and 2023. Results. Annual registered cases decreased from 950 in 2015 to 500 in 2024(−47.4%)in the dissertation series. The reported share attributed to sexual transmissionincreasedfrom 23.6% to 60.2%, whereas the injecting-related share decreased from72.4%to21.4%.The dissertation reports 15,857 cumulative registrations by the end of 2023. Discrepancieswith external published aggregates were identified and require reconciliation. Conclusion. These findings describe changes in reported surveillance indicators, notnecessarily in true HIV incidence. Consistent case definitions and verificationagainstoriginal surveillance records are needed before definitive interpretation. Keywords: HIV, Tajikistan, epidemiology, transmission routes, surveillance,retrospective analysis.
Achieving gender equality requires the support of all genders, but efforts to engage men in women’s empowerment initiatives have been fraught with resistance. Existing research demonstrates that men often anticipate negative consequences for opposing patriarchal norms but has less frequently addressed variability in such perceptions within communities and their modification by socioecological change. Here, we examine the ramifications men face when deemed supportive of women’s empowerment with regard to their social status and prospects for marriage and reproduction, and how these ramifications are shifting with urbanization. Data come from a Tanzanian community, selected because it combines patriarchal norms, with shifting gender roles accompanying urbanization, offering a relevant case for understanding gender norm change in similar low and middle-income settings. Focus groups and in-depth interviews with community members (young men, young women, and elders) confirm severe social costs for men who support women’s empowerment, primarily in the form of reputational damage and social ostracism. Both men and women also frequently question the sexuality, desirability, and reproductive prospects of men engaging in gender atypical behaviors that support women. However, these costs are giving way to emerging incentives for a subset of supportive men who gain social prestige, at least among relatively well-educated peers, via their association with ‘modern’ values, attractiveness to women, access to novel employment opportunities, and adaptability to urban life. Through identifying entrenched costs for supportive men and emerging incentives accompanying urbanization, this study contributes to a deeper understanding of the barriers and pathways to effectively engaging men in women’s empowerment.
New pyrazolo[3,4-d]pyrimidine derivatives 7a-h and 8a-h were synthesized and evaluated for their in vitro inhibitory potential against COX-1, COX-2, 5-LOX along with the NO release inhibitory activity to assess their anti-inflammatory potential. Most compounds confered inhibitory activity at a micromolar level and exhibited prominent selectivity towards COX-2 especially in the 8a-h series. The most useful compound 8e as a COX-2/5-LOX dual inhibitor, exhibited IC50 results of; 1.837 µM for COX-2, 2.662 µM for 5-LOX with an acceptable NO release inhibition rate of 66.02 %. Compounds 7e, 7f, 8e and 8f proved their efficiency as 5-LOX/NO release dual inhibitors; with IC50 values of 2.833, 1.952, 2.662 and 1.573 µM, respectively for 5-LOX biotarget, and with superior NO inhibitory ratio of 73.85, 65.57, 66.02 and 72.28 %, respectively. The in vivo anti-inflammatory assay explored that 7e is the most effective with minimal gastric ulceration prevalence. Molecular docking in the active site of both COX-2 and 5-LOX showed that, the most active 8e and 7e are correctly oriented inside the COX-2 binding pocket with unique binding mode independently on the reference celecoxib. Also, they demonstrated superior binding affinities to the 5-LOX enzyme over both the Zileuton as a reference drug and the normal ligand 30Z. The stability of the complex formed between the most promising candidates 7e or 8e with the COX-2 and 5-LOX active sites, was considered using a typical atomistic 100 ns dynamic simulation study. Investigation of the SAR revealed the importance of both the sulfonamide group in the 8a-h series and the substituents of the 3-phenyl ring tethered on the 1,2,4-oxadiazole core.
Background:Intimate partner violence (IPV) is a significant public health issue, closely tied to social and neighborhood environments. The impoverished, overcrowded, and stressful conditions in urban slums may heighten IPV risk, yet evidence remains limited. This study aims to assess the prevalence, disparities, and trends of IPV in urban slums across low- and middle-income countries (LMICs). Methods:This cross-sectional study used nationally representative Demographic and Health Surveys data from 2006 to 2023, focusing on countries with available domestic violence data for women aged 15-49. The outcomes measured include past-year exposure to any IPV (primary outcome) and physical IPV, sexual IPV, and psychological IPV (secondary outcomes). We examined both absolute and relative disparities between urban slums, non-slum urban, and rural areas using differences and ratios. Additionally, we used Fairlie decomposition analysis based on a multivariable logistic regression model to examine the contributions of IPV risk factors (i.e., poor partner relationships, gender inequality, and poverty) to the disparities. For countries with multiple surveys, we conducted trend analysis by assessing annual changes in IPV prevalence in urban slums and the disparities. Findings:Among 283,658 women from 34 LMICs, 14,111 (5.0%) lived in urban slums. IPV prevalence in urban slums was notably high, with 18 of the studied countries above 30% for any IPV. Women in urban slums experienced higher IPV rates than those in non-slum urban and rural areas. For example, the prevalence of any IPV in urban slums was 31.4% (95% confidence interval [CI]: 30.7-32.2), which was 5.9 percentage points (95% CI: 5.1-6.7, P < 0.0001) higher than that in non-slum urban areas and 1.2 percentage points (95% CI: 0.4-2.0, P = 0.0022) higher than that in rural areas. Controlling behavior by husbands explained the largest proportion of disparities in all IPV types between urban slums and other areas. For example, 27.2% (95% CI: 25.1-29.3) of the any IPV disparities between urban slums and non-slum urban areas could be explained by this factor. In ten countries with multiple surveys, trend analysis showed rising any IPV prevalence in urban slums of four countries-Sierra Leone, Tanzania, Mali, and Nigeria-with Sierra Leone having the most significant increase (4.6 percentage points, 95% CI: 2.5-6.6, P < 0.0001). Interpretation:Our findings suggest that IPV is more prevalent in urban slums than other areas, underscoring the need for targeted public health strategies, such as addressing harmful partner's behaviors. Funding:This research was supported by China National Natural Science Foundation and the Research Fund, Vanke School of Public Health, Tsinghua University.
Mycobacterium tuberculosis (MTB) continues to pose a significant threat to public health, particularly with the emergence of drug-resistant strains. Research shows that first-line antituberculosis drugs are increasingly failing, and second-line drugs are also showing resistance. This study investigates the evolutionary dynamics of second-line drugs used against MTB, specifically Bedaquiline, Delamanid, Linezolid, Clofazimine, and Levofloxacin. Data were collected from the Tanzania National Institute of Medical Research (NIMR) at the Central Tuberculosis Reference Laborator Muhimbili Centre (CTRL). The data were analysed using a 5-hypercubic model, with parameters estimated using the Baum-Welch algorithm. The findings show that the most probable drug-resistant acquisition, independent of other drugs analysed, is Bedaquiline with a probability of 0.8660 and Levofloxacin with a probability of 0.134. The evolutionary pattern begins with Bedaquiline, followed by Levofloxacin, then Clofazimine, and finally either Linezolid or Delamanid, each with an equal probability of occurring. This highlights the evolutionary patterns of drug resistance, providing insights that can inform health experts and policymakers in developing evidence-based, effective interventions to combat this growing public health challenge.